Imugene Ltd has released a press release.
Rights Issue Results & Shortfall Notification
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Imugene
- Imugene raises $8.7 million
- Response to ASX Price Query
- IMU Receives $1.1m R&D Tax Refund
- First Patient Dosing Commences of HER-Vaxx
- Imugene granted Canadian patent for Her-Vaxx cancer vaccine
Later from Imugene
- Business Update - December Quarter Appendix 4C
- Cancer vaccine shows early promise in clinical trial
- IMU Meets Investigator for Gastric Cancer Clinical Trial
- Novel Anti-PD-1 Mimotope Vaccine Ready for Development
- Arginine Modulator Active in Cancer Models
Follow Imugene into a list and get an email when it puts out news.
Follow Imugene